REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,285,736 | -90.8% | 123,821 | -86.5% | 0.02% | -92.3% |
| Q3 2022 | $24,793,000 | +2723.8% | 918,275 | +1345.6% | 0.20% | +2700.0% |
| Q2 2022 | $878,000 | -32.3% | 63,520 | -4.4% | 0.01% | -22.2% |
| Q1 2022 | $1,296,000 | -66.3% | 66,451 | -71.8% | 0.01% | -65.4% |
| Q4 2021 | $3,844,000 | +263.3% | 235,524 | +261.4% | 0.03% | +160.0% |
| Q4 2019 | $1,058,000 | -67.1% | 65,176 | -73.6% | 0.01% | -74.4% |
| Q3 2019 | $3,215,000 | +3.8% | 247,291 | +3.5% | 0.04% | -9.3% |
| Q2 2019 | $3,098,000 | +343.2% | 238,847 | +364.7% | 0.04% | +207.1% |
| Q2 2016 | $699,000 | -51.7% | 51,400 | -38.0% | 0.01% | -54.8% |
| Q1 2016 | $1,447,000 | – | 82,890 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |